Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Condition: Diabetes Interventions: Drug: Glimepiride; Drug: Liraglutide Sponsor: Brigham and Women's Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2021 Category: Research Source Type: clinical trials
